Jan 22, 2026
Jan 27, 2026
P&L%:
-57.43%
Net P/L $:
$-352.04
Performance Metrics
No patterns
| Entry CPU | 2.02 | Price P/L $ | $-348.00 |
| Exit CPU | 0.86 | Div P/L $ | $0.00 |
| Fees | $4.04 | Gross P/L $ | $-348.00 |
| Reg Fees | $0.07 | Net P/L $ | $-352.04 |
| Commissions | $3.97 | P&L% | -57.43% |
| Cash Div. | $0.00 | Total Ret. % | -57.43% |
| Max Qty | 3 | Open P/L $ | $0.00 |
| Current Qty | 0 | Open P&L% | 0.00% |
| Max Cost | $606.00 | Open Value | $0.00 |
Featured Image / Proof
No featured image uploaded for this trade
Using underlying symbol IBRX for option contract chart.
Healthcare • Biotechnology
| Price | $8.05 | Prev Close | $7.76 | Mkt Cap | $8.43B |
| Enterprise Val | $9.18B | P/E (TTM) | — | Forward P/E | 76.67 |
| EPS (TTM) | -0.88 | Forward EPS | 0.11 | Book/sh | -0.83 |
| ROE | — | Debt/Eq | — | Current Ratio | 6.67 |
| Short Interest | 138.11M | Short Float | 0.36% | Short Ratio | 9.31 |
| Avg Vol | 22.83M | Div Yield | — | Next Earnings | 2026-08-04 |
Auto-generated Chart Asset
Notes
No notes added for this trade yet.
Transactions
2 entries| Date | Side | Amount | Price | Commission | Exchange / SEC | Current amt | Current value |
|---|---|---|---|---|---|---|---|
| Jan 27, 2026 08:53:27 | Exit | ||||||
| Jan 22, 2026 11:43:23 | Entry |